Evidence map›Paper›PMID 41748700›Full record

ArticleScientific reports2026

Artificial intelligence-assisted optimization of Lentinula edodes extracts for enhanced bioactive profile and therapeutic potential.

Mustafa Sevindik, Vadim Tagirovich Khassanov, Ayşenur Gürgen, Ilgaz Akata

Abstract read
In one paragraph

Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Mustafa SevindikDepartment of Biology, Faculty of Engineering and Natural Sciences, Osmaniye Korkut Ata University, 80000, Osmaniye, Türkiye. sevindik27@gmail.com.
Vadim Tagirovich KhassanovDepartment of Plant Protection and Quarantine, S. Seifullin Kazakh Agrotechnical Research University, 010000, Astana, Kazakhstan.
Ayşenur GürgenDepartment of Industrial Engineering, Faculty of Engineering and Natural Sciences, Osmaniye Korkut Ata University, 80000, Osmaniye, Türkiye.
Ilgaz AkataDepartment of Biology, Faculty of Science, Ankara University, 06000, Ankara, Türkiye.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In this study, extraction parameters to increase the biological activities of Lentinula edodes extracts were optimized using both Response Surface Methodology (RSM) and Artificial Neural Network-Genetic Algorithm (ANN-GA) hybrid models. Antioxidant, anticholinesterase, antiproliferative activities, and phenolic contents of the extracts obtained under optimum conditions were determined. According to the findings of the study, it was determined that the extracts obtained with ANN-GA optimization had higher TAS (6.612 mmol/L), FRAP (176.25 mg TE/g), and DPPH (133.00 mg TE/g) values ​​compared to RSM. In addition, TOS (4.167 µmol/L) and OSI (0.063) levels were lower. In anticholinesterase assays, ANN-GA extracts were found to be more effective than RSM in inhibiting AChE (72.47 µg/mL) and BChE (132.13 µg/mL). Furthermore, in antiproliferative assays on A549, MCF-7, and DU-145 cancer cell lines, ANN-GA-optimized extracts were observed to have stronger cytotoxic effects. LC-MS/MS analyses revealed that ANN-GA optimization enriched biologically important phenolic compounds such as gallic acid, protocatechuic acid, and caffeic acid at higher levels. Consequently, AI-assisted optimization offers a powerful strategy for enhancing the biological value of mushroom extracts.

Indexed as

Artificial IntelligenceShiitake MushroomsAntineoplastic AgentsAntioxidantsCell Line, TumorCell ProliferationCholinesterase InhibitorsGenetic AlgorithmsHumansNeural Networks, ComputerPhenolsAntineoplastic AgentsAntioxidantsCholinesterase InhibitorsPhenolsAnticholinesterase activityAntioxidant activityAntiproliferative effectArtificial neural network–genetic algorithmExtraction optimizationPhenolic compoundsResponse surface methodology

Identifiers

PMID41748700
PMCPMC13047034

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.